Are they prepared from recovered patients or synthetically?
I seem to remember an article that bamlanivimab is no longer to be used.
Sorry. Engineer and interested in everything.
bamlan is a very viable treatment option and being used. We also just got authorization to use tolicuzumab (actemra) an IL-6 inhibitor in oatients in their first 24 hours in ICU. We are gradually developing targeted treatments and learning when they are most effective. Combined with widespread vaccination we are making good headway against this thing
it is a monoclonal antibody